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Abstract
Background: Bone morphogenetic protein (BMP)7 evokes both inductive and axon orienting responses in dorsal
interneurons (dI neurons) in the developing spinal cord. These events occur sequentially during the development
of spinal neurons but in these and other cell types such inductive and acute chemotactic responses occur
concurrently, highlighting the requirement for divergent intracellular signaling. Both type I and type II BMP
receptor subtypes have been implicated selectively in orienting responses but it remains unclear how, in a given
cell, divergence occurs. We have examined the mechanisms by which disparate BMP7 activities are generated in
dorsal spinal neurons.
Results: We show that widely different threshold concentrations of BMP7 are required to elicit the divergent
inductive and axon orienting responses. Type I BMP receptor kinase activity is required for activation of pSmad
signaling and induction of dI character by BMP7, a high threshold response. In contrast, neither type I BMP
receptor kinase activity nor Smad1/5/8 phosphorylation is involved in the low threshold orienting responses of dI
axons to BMP7. Instead, BMP7-evoked axonal repulsion and growth cone collapse are dependent on
phosphoinositide-3-kinase (PI3K) activation, plausibly through type II receptor signaling. BMP7 stimulates PI3K-
dependent signaling in dI neurons. BMP6, which evokes neural induction but does not have orienting activity,
activates Smad signaling but does not stimulate PI3K.
Conclusions: Divergent signaling through pSmad-dependent and PI3K-dependent (Smad-independent)
mechanisms mediates the inductive and orienting responses of dI neurons to BMP7. A model is proposed whereby
selective engagement of BMP receptor subunits underlies choice of signaling pathway.
Background
Factors first identified as inductive signals that regulate
cell fate and tissue organization have recently been
shown to have crucial roles in acute activities such as
growth cone guidance and axon path finding [1]. This
principle emerged from studies of the developmental
actions of fibroblast growth factors and bone morphoge-
netic proteins (BMPs) [2-4], and has been shown more
recently also to apply to Wnt [5,6] and Hh [7] signaling.
These observations pose the question of how distinctive
developmental activities can be generated by the same
ligand. In principle, a number of strategies might
achieve such a dichotomy: different presentation of the
ligand and/or mechanisms of selective receptor engage-
ment could activate distinct intracellular pathways. The
initiation of parallel or divergent signaling cascades pre-
sumably lies at the heart of distinct cellular events. But
where and how such signaling pathways diverge remains
unclear.
BMPs trigger long-term inductive signaling events that
involve gene transcription and/or the acute cellular
responses of chemotaxis and axon orientation, in both
neurons and non-neuronal cells [3,8]. Instances in
which long-term and acute responses to the same BMP
can occur concurrently in a single cell, illustrated in
monocytes [9,10], emphasize the requirement for diver-
gent pathways and selective regulation of their activa-
tion. One cellular system that relies on sequential but
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of sensory projection neurons in the dorsal horn of the
spinal cord. BMPs supplied by the roof plate initially
specify the fates of several subsets of dorsal interneurons
(dI neurons), directing expression of dI neuron class-
specific transcription factors [11-14]. Subsequently,
BMPs orient the axons of these post-mitotic dI neurons,
directing their growth away from the dorsal midline
[3,4,15] and also regulate the rate of growth of dI axons
as they extend through the spinal cord [16]. Both orien-
tation and rate of growth appear to occur within min-
utes in vitro, suggesting they are regulated
independently of the early inductive BMP pathways.
Moreover, intriguingly, whereas the two highly related
roof plate-derived BMPs, BMP7 and BMP6, both induce
the differentiation of dI neurons [3,4,12,13], BMP7, but
not BMP6, is also able to orient dI axons in vitro and is
required for appropriate dI axon projections in vivo
[3,4].
How BMPs signal the distinct activities in spinal neu-
rons is unclear. The slow time course and molecular
changes in dI neuronal specification in response to
BMPs imply activation of a nuclear signaling pathway.
The core pathway underlying the transduction of BMP
signals from the surface of a cell to the nucleus typically
involves ligand-induced recruitment and activation of a
BMP receptor complex, which comprises one pair each
of type I and type II receptor subunits. BMP binding
promotes phosphorylationo ft y p eIb yt y p eI IB M P
receptors [17,18]. Activated type I BMP receptors phos-
phorylate receptor-associated Smad1/5/8 proteins,
resulting in nuclear translocation of Smad complexes
and activation or repression of transcription of BMP tar-
get genes [18,19]. In monocytes, BMP7 and BMP6 acti-
vate Smad1/5/8 phosphorylation and Smads are
required for gene induction [10]. However, a role for
Smads as intracellular mediators in the induction of dI
neuron-specific genes by BMPs has not been demon-
strated and the question of how this pathway is trans-
duced remains unsolved. In contrast to BMP-induced
neural specification, the rapid time course of BMP-
evoked growth cone orienting responses of dI neurons
points to the recruitment of acute, transcription-inde-
pendent pathways [3]. Although there is a growing
appreciation of the existence of transcription-indepen-
dent responses to BMPs, much less is known about
acute BMP signaling than its classical inductive counter-
part. In monocytes, Smad4 appears not to be required
for BMP7-evoked chemotaxis [10]. Moreover, although
in monocytes and other cell systems, effectors of cytos-
keletal dynamics, such as PI3K, LIMK, and Rho family
GTPases have been implicated as mediators of BMP-sti-
mulated responses [10,16,20,21], their role in BMP-
evoked axon orientation in dI neurons remains to be
determined. Indeed, recent studies suggest that the acti-
vation of LIMK by BMPs regulates the rate of extension
of dI axons, but not their orienting response to BMP7
[16].
Elucidating signaling components is an important step
towards understanding the differential selection of trans-
duction pathways, but how might BMPs activate distinct
intracellular signaling pathways? Experiments on BMP7-
evoked gene induction and chemotaxis in monocytic
cells suggest that recruitment of different canonical
BMP receptor subunits may represent an early step in
triggering divergent signaling paths. Most tellingly,
although it seems likely that type II BMP receptors are
required, the inductive pathway does not appear to
depend on a specific type II receptor, whereas the selec-
tive involvement of two of the three known type II BMP
receptor subunits, ActRIIA and BMPRII, is required for
BMP7-evoked chemotaxis [10]. The view that activation
of particular type II BMP receptors is sufficient to initi-
ate transcription-independent, acute cellular responses is
supported by the observation that PI3K and LIMK can
bind directly to the intracellular domains of type II
BMP receptors [22-24]. Moreover, the BMPRII subunit
has been implicated in eliciting LIMK-dependent
responses to BMPs [16,22]. However, the evidence that
type II BMP receptors direct acute signaling that
diverges from the classical inductive events does not
resolve whether they act in the context of the canonical
type I/type II BMP receptor complex. Type I BMP
receptor activity has been linked previously with activa-
tion of transcriptional BMP responses [14,25,26]. Never-
theless, the loss of BMPRIB in dI neurons and in ventral
retinal ganglion neurons results in aberrant axon gui-
dance [27,28]. From all these studies, a model is emer-
ging in which canonical type I and type II BMP
receptors support both the inductive specification and
axon orienting activities of BMPs but the nature of the
complex that drives orientation and the role of the indi-
vidual receptor subunit activity remain unclear.
In the light of these findings, we have begun to resolve
how BMPs exert their dual developmental effects on dI
neurons by further evaluating the contributions of BMP
receptor subunits and downstream signaling pathways
to the inductive specification and axon orienting activ-
ities of BMP7. We have also examined how the selectiv-
ity of such responses is achieved. We have exploited the
difference in axon orienting ability between BMP7 and
BMP6, comparing requirements for their activities in
neurons isolated in dissociated culture and in spinal
explants. We demonstrate divergent BMP signaling
pathways that operate concomitantly: a classical type I
BMP receptor kinase-mediated path to BMP7-evoked
Smad activation and neural specification, and a pathway
dependent on PI3K activity, which independently
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BMP7. Our results suggest a model in which BMP-
evoked inductive specification in the dorsal spinal cord
depends on type I BMP receptor activity and involves
classical Smad signaling to the nucleus, whereas BMP7-
elicited axon orientation depends on activation of PI3K
signaling independent of type I BMP receptor activity
and the Smad cascade, through differential engagement
of type II BMP receptor subunits.
Results
Different concentration thresholds for Smad activation
and growth cone collapse
We assessed whether there are differences in the initia-
tion of BMP-evoked events in dI neurons, examining
whether the inductive specification and axon orienting
actions of BMP7 on dI neurons are evoked at different
ligand concentrations. Initially, to determine an effective
concentration range, we monitored the threshold for
induction of dI1 neurons, a major class of spinal projec-
tion neurons. Explants of chick intermediate neural tube
([i] explants) were exposed to a range of BMP concen-
trations and examined after 48 h for the differentiation
of dI1 neurons, marked by expression of the LIM home-
odomain proteins Lhx2 and Lhx9 [11,29]. The threshold
for expression of dI1 neuronal markers was approxi-
mately 5 ng/ml BMP7 or BMP6 (Figure 1A), with robust
Lhx2/9 expression observed at 50 ng/ml (Figure 1A).
We now examined whether different classes of BMP
response can be evoked concomitantly in individual dI
neurons and whether these responses are initiated at dif-
ferent BMP ligand concentrations. We monitored BMP-
evoked phosphorylation of Smad1/5/8 as an early step
in the classical transcriptional signaling pathway.
Smad1/5/8 phosphorylation was measured both by wes-
tern blot analysis of dI neuronal lysates and by immuno-
fluorescent labeling of dI neuron cultures. In sister
cultures, we also measured growth cone collapse, as an
example of an acute response to BMP7, occurring
within minutes, and considered a surrogate for the axo-
nal orientation response [3]. Growth cone collapse in
the presence of BMPs was compared by measuring the
growth cone area in dI neuron cultures, using ezrin-
radixin-moeisin (ERM) immunoreactivity to visualize the
growth cone [3].
Cultures of dissociated dI neurons were exposed to
BMP7 and BMP6 at two concentrations: 50 ng/ml,
based on the observation of dI neuronal specification in
[i] explants (Figure 1A), and 0.01 ng/ml, a concentration
sufficient to elicit monocyte chemotaxis [10]. At 0.01
ng/ml neither BMP7 nor BMP6 evoked Smad1/5/8
phosphorylation (Figure 1B), but at 50 ng/ml both
ligands stimulated phosphorylation of Smad1/5/8 (7.8-
a n d6 . 8 - f o l do v e rc o n t r o lv a l u e sf o rB M P 7a n dB M P 6 ,
Figure 1 dI induction, Smad activation and growth cone
collapse by BMPs. (A) Lhx2/9 induction in [i] explants treated with
BMP7 or BMP6. Scale = 50 μm. (B) pSmad1/5/8 response to BMP7
or BMP6 in dI neurons. Western blots of whole cell lysates. Results
(mean ± SEM), normalized to total cellular Smad1/5/8, are expressed
as percent control pSmad1/5/8 (at 0.01 ng/ml BMP7 = 68 ± 13%
and BMP6 = 66 ± 4% (n = 2); at 50 ng/ml BMP7 = 780 ± 247% and
BMP6 = 675 ± 199% (n = 5)). Mann-Whitney tests: the pSmad1/5/8
response at 50 ng/ml BMP7 and BMP6 was significantly different
from control (**P < 0.01); the pSmad1/5/8 response at 0.01 ng/ml
BMP7 and BMP6 was not different from control (P = 0.0952). (C)
Dissociated dI neurons ±50 ng/ml BMP7 or BMP6, double-labeled
with phospho-specific a-Smad1/5/8 (red) and DAPI (blue): 95.2 ±
2.0% (BMP7) and 97.9 ± 1.5% (BMP6) dI neurons were pSmad1/5/8
+.
Scale = 20 μm. (D) ERM)-labeled dissociated dI neurons ±BMP7 at
0.01 or 50 ng/ml. Arrowheads indicate typical widespread growth
cones and asterisks indicate collapsed growth cones. Scale = 20 μm.
(E) Average growth cone areas (mean ± SEM): control = 107.6 ±
0.44 μm
2; BMP7 (0.01 ng/ml) = 57.8 ± 1.11 μm
2; BMP7 (50 ng/ml) =
63.4 ± 0.85 μm
2. Areas measured in 0.01 or 50 ng/ml BMP7 differ
significantly from control (***P < 0.001, Student’s t-test). Results are
for 140 to 380 growth cones/condition/experiment; n = 2. (F)
Comparison of dI growth cone responses to BMP7 and BMP6 (50
ng/ml), measured as in (E): control = 114.3 ± 10.7 μm
2; BMP7 = 79.5
± 7.4 μm
2; BMP6 = 127.4 ± 11.9 μm
2. Student’s t-tests: area in BMP7
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(pSmad1/5/8) labeling detected in > 95% of all neurons
(Figure 1C). In sister cultures, BMP7 elicited similarly
robust growth cone collapse at both test concentra-
tions, causing 46% (0.01 ng/ml) and 41% (50 ng/ml)
decreases in the average growth cone area of dI neu-
rons (Figure 1D,E). In contrast, BMP6 did not elicit
growth cone collapse (Figure 1F). Although technical
difficulties prevent the use of both ERM and pSmad1/
5/8 immunoreactivity in the same cells, in sister cul-
tures 50% of neurons showed growth cone collapse
and 95% showed Smad1/5/8 phosphorylation. These
results show that BMP7 stimulates both pSmad1/5/8
activation and growth cone collapse in individual neu-
rons, that BMP6 can elicit only pSmad1/5/8 activation,
and that these activities are elicited at different thresh-
old concentrations of BMP7.
Type I BMP receptor signaling participates in inductive
specification but not axon orientation
Distinct thresholds for BMP-evoked inductive specifi-
cation and axonal orientation raise the possibility that
different receptor proteins signal these two activities,
supporting the findings suggesting differential roles
for type I and type II receptors in spinal cord and in
monocytes [10,28]. We therefore explored whether the
inductive and orienting responses of spinal neurons to
BMP7 involve the activity of different BMP receptor
subunits and/or intracellular signaling pathways. Type
I BMP receptors are classically associated with activa-
tion of the Smad cascade. However, knock-down
experiments have implicated the type I BMP receptor
BMPRIB in roof plate-evoked spinal axon orientation
[28]. We now further examined the roles of type I
BMP receptors in BMP-evoked Smad activation and
dI neuron inductive specification and in axon orienta-
tion by testing the consequences of blocking the activ-
ity of type I BMP receptor kinase. We used
dorsomorphin (DM), an inhibitor of type I BMP
receptor kinase activity [30,31], to assess the require-
ment for the activity of type I BMP receptors in disso-
ciated dI neurons.
We first examined the effect of DM on levels of
Smad1/5/8 phosphorylation evoked by 50 ng/ml BMP7
or BMP6. Initially, we tested a range of DM concentra-
tions to determine an effective dose (see Materials and
methods). At 10 μM, DM eliminated BMP-induced
Smad1/5/8 phosphorylation, measured by both western
blot analysis of whole cell lysates (Figure 2A) and
Figure 2 BMP-evoked Smad1/5/8 phosphorylation, but not
collapse activity, depends on type I BMP receptor kinase
activity. (A) Whole cell lysates of dissociated dI neurons with or
without DM (10 μM) and with or without BMP7 or BMP6 (50 ng/ml),
probed and normalized on western blots as in Figure 1B. Results are
expressed as percentage of control pSmad1/5/8 for each condition
(BMP7 - DM = 188 ± 28%; BMP7 + DM = 104 ± 3%; BMP6 - DM =
191 ± 25%; BMP6 + DM = 122 ± 13%; n = 2). DM had no effect on
baseline pSmad1/5/8 (control + DM = 100 ± 13%). pSmad1/5/8
responses to BMP7 and BMP6 treated with DM differ significantly
differs significantly from control (***P < 0.001); area in response to
BMP6 was not different from control (P = 0.0607). Results are for
100 to 115 growth cones/condition/experiment; n = 2.
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rons (Figure 2B), indicating blockade of type I BMP
receptor activity. We next assessed whether BMP7-
evoked growth cone collapse was affected by DM in
sister cultures of dissociated dI neurons. Exposure to
BMP7 (50 ng/ml) evoked a 36% decrease in the aver-
a g eg r o w t hc o n ea r e ao fd In e u r o n s( F i g u r e2 C ) .D M
(10 μM) had no significant impact on the growth cone
collapsing activity of BMP7 (BMP7 + DM = 32%
decrease in growth cone area; Figure 2C). Thus, DM
effectively inhibits BMP-evoked Smad1/5/8 phosphory-
lation but not growth cone collapse in dI neurons.
These data provide evidence that type I BMP receptor
kinase activity is not required for BMP7-evoked growth
cone collapse. They also indicate that activation of
cytoskeletal dynamics by BMP7 occurs through a path-
way distinct from the Smad cascade.
We next examined the impact of type I BMP recep-
tor kinase blockade on the specification and axonal
orientation of dI neurons within spinal cord explants.
In [i] explants, analysis of BMP-evoked stimulation of
pSmad1/5/8 confirmed that phosphorylation of Smad1/
5/8 by both BMP7 and BMP6 is abolished by treat-
ment with DM (Figure 3A, upper panels). The ability
of DM to alter BMP-evoked induction of Lhx2/9
+ cells
was tested in [i] explants, in which individual cells
expressing Lhx2/9 can be counted. In control explants,
BMP7 induced expression of Lhx2/9 (7.7 ± 1.0 Lhx2/9
+ cells per 100 μm
2; Figure 3A, lower panels). Treat-
ment of [i] explants with BMP6 yielded similar results
(8.6 ± 1.6 Lhx2/9
+ cells per 100 μm
2; Figure 3A, lower
panels). In the presence of DM (5 μM), induction of
Lhx2/9 by both BMP7 and BMP6 was abolished (0
cells; Figure 3A, lower panels). Thus, DM blocks
Smad1/5/8 phosphorylation and dI1 neuronal specifi-
cation by BMPs in spinal [i] explants.
Based on these findings, we monitored the effects of DM
in explants of rat dorsal spinal cord ([d] explants), in
which BMP-evoked Lhx2/9 induction and dI axon orienta-
tion can be examined in parallel [3,4]. In control explants
cultured adjacent to pellets of COS-1 cells expressing an
empty vector, expression of Lhx2/9 was restricted to dor-
sal regions of the explants (Figure 3B(a)) with a pattern
similar to that observed in sections of embryos taken at
the same age (not shown). Endogenous Lhx2/9 expression
was unaffected by DM treatment (Figure 3B(b)). In [d]
explants co-cultured with BMP7-expressing COS-1 cells,
ectopic Lhx2/9 expression was observed (Figure 3B(c)).
The dorsal to ventral (D-V) extent of Lhx2/9 expression
was expanded, reflecting a 3.1-fold increase in dI1 neurons
(Figure 3B(c),3C). DM treatment (10 μM) substantially
reduced ectopic Lhx2/9 expression induced by BMP7 in
[d] explants by 39% (BMP7 + DM = 1.9-fold over control;
Figure 3B(d),3C), corroborating the result in [i] explants
(Figure 3A) and providing further evidence that BMP-
mediated specification of dI1 neurons require type I BMP
receptor kinase activity. The effect of DM on the orienta-
tion of TAG-1
+ dI axons was examined in the same [d]
explants as those used to measure Lhx2/9 induction (Fig-
ure 3B). In [d] explants cultured adjacent to control COS-
1 cells expressing empty vector, dI axons extended with a
D-V trajectory (angle of reorientation (pMT23) of 5.1 ±
1.3°; Figure 3D,E). In [d] explants exposed to BMP7-trans-
fected COS-1 cells, TAG-1
+ axons were repelled, extend-
ing away from the BMP7 source, with an angle of
reorientation of 30 ± 3.1° (Figure 3D,E). Although ectopic
Lhx2/9 expression was reduced when DM (10 μM) was
applied to the [d] explants (Figure 3B,C), no change was
observed in the response of dI axons to BMP7 in the pre-
sence of DM (angle of reorientation of 28.4 ± 3.3°; Figure
3D,E). The lack of effect of DM on dI axon orientation
parallels the resistance of BMP7-evoked growth cone col-
lapse to blockade of type I BMP receptor kinase activity
(Figure 2C).
From these results we infer that type I BMP receptor
activity, potentially acting through the Smad cascade,
initiates the BMP7- and BMP6-evoked pathway of
inductive specification, but although type I receptor sub-
units may be required as part of the functional receptor
complex [28], type I BMP receptor kinase activity is not
required for BMP7-evoked axon orientation. Taken
together, our results argue that divergence of dI neuron
inductive and orienting responses stems from distinct
BMP:receptor interactions in which BMP7, at low con-
centrations, and BMP7 and BMP6, at high concentra-
tions, engage different receptors within the receptor
complex. These considerations led us to examine which
type II BMP receptors and associated downstream
from pSmad1/5/8 responses to BMP7 and BMP6 without DM (*P <
0.05, Mann-Whitney test). (B) Left: pSmad1/5/8 in dissociated dI
neurons with or without BMP7 and with or without DM. Scale = 80
μm. Insets: pSmad1/5/8-positive and -negative neurons (scale = 10
μm). Right: the percentage of pSmad1/5/8
+ neurons in control
cultures with or without DM was unchanged (control - DM = 5.4 ±
4.7%; control + DM = 4.5 ± 4.1%; P = 0.8977, Student’s t-test). The
number of pSmad1/5/8
+ cells in response to BMP7 with or without
DM differed significantly (BMP7 - DM = 53.1 ± 1.2%; BMP7 + DM =
4.7 ± 1.8%; **P < 0.005, Student’s t-test). Results are mean ± SEM for
four 20 × fields: 150 to 500 neurons/condition/experiment (n = 2).
(C) ERM-labeled dissociated dI neuron sister cultures, with or
without BMP7 and with or without DM as in (B). The growth cone
area in control cultures was not changed by DM (not shown;
control - DM versus control + DM, P = 0.9215 (Student’s t-test)). The
percentage decrease in growth cone area in response to BMP7 was
not significantly altered by DM: control + DM = 1.3 ± 11%; BMP7 -
DM = 36 ± 4%; BMP7 + DM = 32 ± 2%; n = 2; BMP7 - DM versus
BMP7 + DM, P = 0.4097 (Student’s t-test)). Arrowhead indicates
control growth cone and asterisks indicate collapsed growth cones.
Scale = 10 μm.
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selectively.
dI neurons express type II BMP receptors
Of the three type II BMP receptors, only ActRIIA and
BMPRII are required for Smad-independent BMP7-
evoked chemotaxis of monocytic cells [10]. Nothing is
k n o w ni nd e t a i lo ft h ein vivo distribution of type II
BMP receptors in embryonic spinal cord. To begin to
explore the possibility that BMP7-evoked growth cone
collapse and orientation involves specific type II BMP
receptors, we determined the distribution of all three
type II BMP receptors in dissociated dI neurons. Wes-
tern blots of dI neuronal lysates showed expression of
Figure 3 Type I BMP receptor kinase activity required for BMP7-evoked Lhx2/9 induction, but not axon orientation. (A) [i] explants
treated with BMP7 or BMP6 (20 ng/ml) with or without DM (5 μM): a-pSmad1/5/8 (upper) and a-Lhx2/9 (lower) panels. Scale = 20 μm. (B-E) [d]
explants, with appended control or BMP7-expressing COS-1 cells, with or without 10 μM DM. Explants co-labeled with a-Lhx2/9 (red) (B), and a-
TAG-1 (green) and a-flag (blue) (C). Scale = 50 μm. (B) Endogenous Lhx2/9, induced prior to explantation, present only in the dorsal-most region
of explants, cultured alone (not shown) or with pMT23-expressing COS-1 cells (a). DM did not alter endogenous Lhx2/9 (b). Dashed lines indicate
ectopic ventral Lhx2/9 expression in [d] explants + BMP7-expressing COS-1 cells (c). DM treatment greatly reduced BMP7-induced ectopic Lhx2/9
(d, arrows). (C) Integrated density of Lhx2/9 expression (mean × 10
5 ± SEM for each condition): pMT23 - DM = 5.41 ± 0.77 (n = 3); pMT23 + DM
= 5.33 ± 0.94 (n = 2); BMP7 - DM = 16.46 ± 2.51 (n = 5); BMP7 + DM = 9.94 ± 1.90 (n = 6). (D) Dashed lines mark appended borders of COS-1
cell aggregates and [d] explants. Arrowheads indicate dI axons repelled by BMP7. (E) Angles of reorientation in [d] explants with pMT23- or BMP7-
expressing COS-1 cells with or without DM (pMT23 = 5.1 ± 1.3° (n = 3); pMT23 + DM = 2.3 ± 0.3° (n = 2); BMP7 = 30 ± 3.1° (n = 5); BMP7 + DM =
28.4 ± 3.3° (n = 5). Results are mean ± SEM for each condition. Student’s t-tests: DM had no effect on the D-V projection of dI axons either in
control (pMT23 versus pMT23 + DM; P = 0.1936) or BMP7-orienting conditions (BMP7 versus BMP7 + DM; P = 0.7345).
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fluorescence analysis of dI cultures, in conjunction with
phase contrast imaging and DAPI nuclear staining to
provide total neuronal counts, revealed that ActRIIA
and BMPRII are the predominant type II BMP receptors
expressed in dI neurons, in 86% (ActRIIA) and 79%
(BMPRII) of neurons, respectively (Figure 4B,C). In con-
trast, ActRIIB was expressed in only 33% of neurons.
ActRIIA and BMPRII are expressed by processes,
growth cones and cell bodies (Figure 4B,C), whereas
ActRIIB is expressed mainly in growth cones (Figure 4B,
C). Thus, the type II receptors necessary for BMP7-
evoked chemotaxis, ActRIIA and BMPRII, are promi-
nently expressed by dI neurons.
BMP7-mediated dI inductive specification is independent
of PI3K signaling
The observations described in the previous section
prompted us to consider the roles of signaling pathways
associated with type II BMP receptors in BMP7-evoked
neuronal activities. We explored the possibility that a
pathway mediated by PI3K might elicit axon orientation
independently of inductive specification. PI3K and
LIMK1 are both associated with type II BMP receptors
[22,23]. Moreover, cell migration and chemotaxis of
non-neuronal cells in response to BMP2 [21,32] and
BMP7 [10] are dependent on PI3K, whereas LIMK
appears to regulate rate, but not direction of, dI axon
extension within the spinal cord [16]. We therefore
examined the role of PI3K activity in BMP-evoked
inductive specification and axon orientation in spinal
explants, using the inhibitors of PI3K activity, LY294002
(LY) and wortmannin (WM) [33].
As shown above (Figure 3A), BMP7 and BMP6 stimu-
lated phosphorylation of Smad1/5/8 and induction of
Lhx2/9 in [i] explants (Lhx2/9
+ c e l l s :B M P 7=7 . 7±1 . 0
cells; BMP6 = 8.6 ± 1.6 cells; Figure 5A,B). Incubation
of [i] explants with LY (2.5 μM) had no effect on
BMP7-evoked pSmad1/5/8 or Lhx2/9 induction (Lhx2/9
+ cells: BMP7 + LY = 7.7 ± 1.9 cells; BMP6 + LY = 6.8
±1 . 7c e l l s ;F i g u r e5 A , B ) .S i m i l a r l y ,i n[ d ]e x p l a n t s ,L Y
treatment had no effect on the inductive response to
BMP7: co-culture of BMP7-expressing COS-1 cells with
[d] explants induced ectopic Lhx2/9 expression (4.9-fold
over control levels; Figure 5C,D). In the presence of LY
(2.5 μM), [d] explants exposed to BMP7 showed a 5.3-
fold increase in Lhx2/9 expression that was not signifi-
cantly different from [d] explants without LY (Figure
5C,D). Together, these results provide evidence that
neither the phosphorylation of Smad1/5/8 nor the intra-
cellular events underlying neural specification by BMP7
employ PI3K as a signaling intermediate.
PI3K involvement in BMP7-mediated growth cone
collapse and axon orientation
We next measured the effect of LY on BMP7-evoked
axon orientation in the same [d] explants in which
Lhx2/9 expression was monitored (Figure 5C). In con-
trol [d] explants co-cultured with adjacent pellets of
COS-1 cells expressing empty vector, axons extended
with a straight D-V trajectory with an angle of reorien-
tation of 0.8 ± 1.7° (Figure 6A,B). In [d] explants adja-
cent to BMP7-expressing COS-1 cells, axons were
repelled, extending away from the BMP source with an
angle of reorientation of 32.5 ± 1.9° (Figure 6A,B). LY
Figure 4 Type II BMP receptor expression in dI neurons. (A)
Western analysis of whole cell lysates of dissociated dI neurons
probed with a-BMPRII (130 kDa, lane 1), a-ActRIIA/B (70 kDa, lane 2)
and a-ActRIIB (58 kDa, lane 3) antibodies. (B) Immunofluorescence
labeling of dissociated dI neurons with antibodies against type II
BMP receptors (a-BMPRII, a-ActRIIA/B and a-ActRIIB). The left
column shows relative numbers of labeled neurons against
background low level fluorescence (scale = 50 μm). The center
column (scale = 20 μm) and right column (scale = 10 μm) highlight
neuronal detail. (C) Direct comparison of ActRIIA and ActRIIB
expression in sister cultures. Phase contrast (left), BMP receptor
immunofluorescence labeling (center) and DAPI nuclear staining
(right) of dissociated dI neurons. Arrowheads indicate ActRIIB
+
growth cones. Analysis of immunofluorescence label for each
antibody from three to four 20 × fields showed that 85.6 ± 3.7% of
1,056 total neurons were ActRIIA
+ (n = 4), 33.1 ± 3.7% of 732 total
neurons were ActRIIB
+ (n = 4) and 78.6 ± 3.3% of 465 total neurons
were BMPRII
+ (n = 3). Scale = 50 μm.
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orient dI axons: in the presence of LY the angle of reor-
ientation in response to BMP7 was 11.6 ± 1.7° (Figure
6A,B), a reduction of orientation of more than 60%. To
control for non-specific effects of LY on orienting
responses of axons in [d] explants, we examined the
effect of LY on Netrin-1-evoked orientation of dI axons
[34]. Axon orientation towards Netrin-1 was unaffected
in the presence of LY (Netrin - LY = 51.5 ± 3.5°; Netrin
+L Y=4 9 . 0±1 . 5 ° ;P = 0.4621 (Student’s t-test); Figure
6A), indicating selective susceptibility of BMP7-evoked
dI axonal responses to inhibition of PI3K signaling.
Thus, the ability of BMP7 to orient dI axons appears
dependent on PI3K signaling.
Members of the MAPK family and cAMP have been
identified as intermediates in Smad-independent signaling
downstream of BMPs and/or associated with axonal gui-
dance responses in other systems [17,35], raising the possi-
bility that they also function in BMP7-activated dI axonal
orientation. We tested inhibitors of MAPKs and modula-
tors of cAMP activity for their ability to regulate BMP7-
evoked dI axon orientation in [d] explants. The angle of
BMP7-evoked axonal reorientation was unchanged by an
inhibitor of PKA (KT5720), by an adenylate cyclase agonist
(forskolin), by an Erk1/2 MAPK inhibitor (PD98059) or by
a p38 MAPK inhibitor (SB203580) (Additional file 1).
These results provide further support for the idea that
PI3K, rather than MAPK activity or cAMP-dependent sig-
naling, mediates the dI axon orienting response to BMP7.
To summarize, treatment with LY selectively blocked
BMP7-evoked axon orientatio ni nt h es a m ee x p l a n t si n
which ectopic Lhx2/9 expression was unaffected, suggest-
ing that PI3K activity is required for the action of BMP7
on dI axon orientation but not dI1 neuronal specification.
To control further for non-specific actions of LY, we
tested a second inhibitor of PI3K activity, WM, in parallel
with LY. We assessed the ability of LY and WM to regu-
late BMP7-evoked growth cone collapse in dissociated dI
neurons. BMP7 alone evoked a 44% decrease in the aver-
age growth cone area of dI neurons (Figure 6C). Incuba-
tion of neurons with BMP7 and either LY (50 μM) or
WM (100 nM) resulted in substantial (75% (LY) and 57%
(WM)) reductions in growth cone collapse (BMP7 + LY
= 14% decrease in average growth cone area; BMP7 +
WM = 19% decrease in average growth cone area; Figure
6C). These results provide pharmacological evidence that
B M P 7 - e v o k e dd Ig r o w t hc o n ec o l l a p s ei sm e d i a t e db ya
PI3K-dependent mechanism.
BMP7, but not BMP6, activates PI3K-dependent
downstream signaling
We next asked whether BMP7 can activate a PI3K-
dependent pathway in dI neurons independent of the
Figure 5 Inhibition of PI3K activity has no effect on BMP7-
induced Lhx2/9 expression. (A) [i] explants treated with BMP7 or
BMP6 (20 ng/ml) with or without 2.5 μM LY and labeled with a-
pSmad1/5/8 (upper panels) and a-Lhx2/9 (lower panels). Scale = 20
μm. (B) Quantification of Lhx2/9
+ cells/100 μm
2 in [i] explants:
BMP7 - LY = 7.7 ± 1.0 cells; BMP7 + LY = 7.7 ± 1.9 cells; BMP6 - LY
= 8.6 ± 1.6 cells; BMP6 + LY = 6.8 ± 1.7 cells; (n = 2) (mean ± SEM
for each condition). LY had no effect on Lhx2/9 expression induced
by either BMP7 or BMP6 (BMP7 - LY versus BMP7 + LY, P = 0.9997;
BMP6 - LY versus BMP6 + LY, P = 0.4942 (Student’s t-test)). (C) Lhx2/
9-labeled (red) [d] explants co-cultured with control- or BMP-7-
expressing COS-1 cells with or without 2.5 μM LY. Double-headed
arrows mark the width of the control and induced Lhx2/9-
expression regions. Scale = 50 μm. (D) Quantification of Lhx2/9
induction in [d] explants, measured as in Figure 3C: pMT23 - LY =
4.48 ± 0.44 (n = 8); pMT23 + LY = 4.85 ± 0.55 (n = 8); BMP7 - LY =
14.02 ± 1.0 (n = 17); BMP7 + LY = 12.42 ± 0.78 (n = 18). Mean ×
10
5 ± SEM for each condition. Student’s t-tests: there was no
difference in the expression levels of Lhx2/9 with or without LY in
either control [d] explant co-cultures (pMT23 - LY versus pMT23 +
LY, P = 0.8002) or BMP7-induced [d] explants (BMP7 - LY versus
BMP7 + LY, P = 0.5978).
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(s). As an indicator of PI3K activity, we used the LY-
sensitive phosphorylation of a major downstream target
of PI3K signaling, Akt [21,36]. The activity of BMP7 was
tested at a concentration that evokes both induction and
orientation. Dissociated dI neuron cultures were treated
with 50 ng/ml BMP7 and whole cell lysates were col-
lected over a series of time points and analyzed by wes-
tern blot. After 15 minutes of BMP7 treatment, pAkt
levels were substantially increased (pAkt level = 1.8-fold
over control; Figure 7A,B) as was Smad1/5/8 phosphory-
lation (pSmad level = 9.1-fold over control; Figure 7A,
C). Pretreatment with LY (50 μM) significantly reduced
the increase in pAkt levels stimulated by BMP7 (BMP7
+ LY pAkt level = 0.7-fold of control; Figure 7A,B). As
in [i] explants, LY had no effect on BMP7-stimulated
pSmad1/5/8 levels in cultures of dI neurons (BMP7 +
LY pSmad level = 11.4-fold over control; Figure 7A,C).
Thus, BMP7 appears to stimulate PI3K activity and by a
pathway that is independent of Smad activation in dI
neurons.
We next examined the selectivity of the Akt response
to BMP7 by testing the two concentrations that distin-
guish BMP7 actions in neural induction and growth
cone collapse (Figure 1). BMP7 stimulated the phos-
phorylation of Akt at both 0.01 and 50 ng/ml (1.53-fold
and 1.45-fold over control, respectively; Figure 8). This
result parallels the finding that BMP7 causes growth
cone collapse at both concentrations, but distinguishes
Akt activation from BMP7-stimulated Smad1/5/8 phos-
phorylation, which occurs only at high concentrations
(Figure 1B). Thus, BMP7 stimulates PI3K activity at
ligand concentrations consistent with a role for PI3K in
the orienting response to BMP7. These observations led
us to determine whether signaling through the PI3K-
dependent mechanism is selectively activated by a BMP
with orienting activity. We compared the abilities of
BMP7 and BMP6 to phosphorylate Akt in dI neurons,
using western blot analysis of dI neuron cultures treated
for 15 minutes with 0.01 ng/ml or 50 ng/ml BMP7 or
BMP6. As described above, BMP7 consistently evoked
increases in pAkt (1.53- and 1.45-fold increases at the
two concentrations). In contrast, BMP6 showed no
increase in pAkt over levels in control cultures (0.8- and
1.1-fold of control, respectively; Figure 8). Taken
together, these results provide evidence that BMP7 acti-
vates a PI3K-dependent pathway under conditions in
which it stimulates the orienting response of dI neurons.
Moreover, the ability of BMP7 to activate this path is
selective to BMP7 over BMP6 and independent of Smad
activation, suggesting that PI3K activity participates in a
Figure 6 BMP7-evoked growth cone collapse and axon
orientation is dependent on PI3K activity. (A) [d] explants
cultured as in Figure 5C with control- or BMP7- (blue; a-flag) or
Netrin-1- (blue; a-Netrin) expressing COS-1 cells, with or without 2.5
μM LY (+LY). Green shows TAG-1-labeled axons. Dashed lines mark
COS-1 cell aggregate and [d] explant appended borders. The closed
single arrowhead indicates dI axons repelled by BMP7. The double
closed arrowheads indicate angle of axons with LY. Open
arrowheads indicate dI axons attracted by Netrin-1. Scale = 50 μm.
(B) Angle of reorientation in [d] explants co-cultured with or
without BMP7 and with or without LY (mean ± SEM for each
condition): pMT23 = 0.8 ± 1.7° (n = 9); pMT23 + LY = -4.3 ± 1.8° (n
= 3); BMP7 = 32.5 ± 1.9° (n = 18); BMP7 + LY = 11.6 ± 1.7° (n = 29).
Student’s t-tests: the straight D-V projection of axons in control [d]
explants was unchanged by LY (pMT23 - LY versus pMT23 + LY, P =
0.1412). BMP7-evoked reorientation was significantly inhibited by LY
(BMP7 - LY versus BMP7 + LY, ***P < 0.0001). Attraction of dI axons
by Netrin-1 was unchanged by LY (Netrin - LY = 51.5 ± 3.5° (n = 3);
Netrin + LY = 49.0 ± 1.5° (n = 4); Netrin - LY versus Netrin + LY, P =
0.4621). (C) BMP7-evoked dI growth cone collapse measured with
or without LY or WM. Percentage decrease of growth cone area
relative to control cultures (mean ± SEM): BMP7 = 44 ± 4% (n = 3);
BMP7 + LY = 14 ± 7% (n = 2); BMP7 + WM = 19 ± 2% (n = 3).
BMP7-stimulated reduction in growth cone area was significantly
different from cultures treated with BMP7 + LY or BMP7 + WM
(BMP7 - LY versus BMP7 + LY, *P < 0.05; BMP7 - WM versus BMP7 +
WM, **P < 0.005; (Student’s t-test)). Results are for 200 to 400
growth cones/condition/experiment.
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inductive specification activity of BMPs.
Discussion
We have examined the nature and divergence of signal-
ing pathways that control transcriptional and cytoskele-
tal responses to BMP7 in dorsal spinal neurons.
Intracellular BMP signaling is communicated through
multiple pathways [17,37] and how and where those
paths diverge or converge is still under study. One pro-
blem, illustrated here for dI neurons, is how a given
BMP directs more than one kind of response in the
same cell either concomitantly or sequentially. Our
results cast light on this issue by demonstrating two
pathways, one activated by both BMP7 and BMP6 and
the other selectively by BMP7, which direct different
cellular activities in dI neurons. These paths diverge
upon receptor activation, suggesting a model (Figure 9)
of recruitment of canonical BMP receptor subunits into
distinct complexes. Under this paradigm, one conse-
quence of BMP binding is dominated by type I BMP
receptor activity leading to initiation of the Smad cas-
cade and activation of nuclear responses. The second
pathway recruits a receptor complex that leads to PI3K-
dependent signaling, presumably to the cytoskeleton.
Type II, rather than type I BMP receptors, are likely to
play the major instructive role in this second pathway
directing axon orienting responses. Although this model
addresses the differential effects of BMP7 in dI neurons,
the parallels with BMP-evoked events in monocytes sug-
gest common principles underlying mechanisms of
Figure 7 BMP7 evokes rapid PI3K-dependent stimulation of
Akt phosphorylation in dI neurons. (A) Dissociated dI neurons
pretreated with or without 50 μM LY and incubated with 50 ng/ml
BMP7 for 0, 2, 5 or 15 minutes. Western blots of whole cell lysates
probed with phospho-specific a-Akt or a-Smad1/5/8, then a-total
cellular Akt protein (to normalize the pAkt signals). (B, C) pAkt (B)
and pSmad1/5/8 (C) levels in the same dI neurons in response to
50 ng/ml BMP7 with or without LY, at 15 minutes. Percentage of
control for each condition (mean ± SEM)): for pAkt, BMP7 - LY =
179 ± 6% and BMP7 + LY = 67 ± 18% (n = 2); for pSmad1/5/8,
BMP7 - LY = 913 ± 175% and BMP7 + LY = 1,143 ± 448% (n = 2).
Student’s t-tests: BMP7-evoked pAkt in dI neurons with LY differs
significantly from pAkt without LY (BMP7 - LY versus BMP7 + LY, *P
< 0.05). BMP7-induced pSmad1/5/8 levels did not differ in dI
neurons with or without LY (BMP7 - LY versus BMP7 + LY, P =
0.6798).
Figure 8 BMP7 but not BMP6 stimulates Akt phosphorylation
in dI neurons. Whole cell lysates of dissociated dI neurons with or
without BMP7 or BMP6, at 0.01 and 50 ng/ml for 30 minutes,
probed on western blots with a-pAkt as in Figure 7A. Percentage of
control for each condition relative to baseline pAkt levels (mean ±
SEM): at 0.01 ng/ml, BMP7 = 153 ± 0.5%, and BMP6 = 82 ± 11% (n
= 2); at 50 ng/ml, BMP7 = 145 ± 12%, and BMP6 = 105 ± 8% (n =
5). Student’s t-tests: pAkt in dI neuron cultures treated with 0.01 or
50 ng/ml BMP7 was significantly different from control pAkt (**P <
0.01, ***P < 0.001). pAkt in cultures treated with 50 ng/ml BMP6 did
not differ from control (P = 0.5628).
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of cellular contexts.
Divergent pathways activated concomitantly in single
neurons
The two responses to BMP7 demonstrated in dI neu-
r o n sa r eb yt h e i rn a t u r ed i s t i n c t .A l t h o u g hi nd In e u -
rons, in vivo, specification and axon guidance occur
sequentially during development, in monocytes BMP7
activates chemotaxis and gene induction in the same
cell concurrently. Similarly, in dissociated dI neurons we
show here that the two divergent pathways can be acti-
vated concurrently. In experiments examining activity of
BMP7 on individual neurons, sister cultures were always
used. In dissociated dI neuron cultures, > 95% of cells
show Smad1/5/8 phosphorylation in response to BMP7
and in sister cultures > 50% show growth cone collapse.
Thus, in at least 45% of the neurons in culture both
pathways are activated by t h es a m ed o s eo fB M P 7 .T h e
use of [d] spinal explants to demonstrate both induction
and axon orientation in response to BMP7 does not
assume that the same neurons responded in both ways
but were used to compare the two responses under the
same pharmacological manipulation.
Distinct downstream pathways underlie inductive and
acute BMP activities
Type I BMP receptor kinase activity appears to mediate
the activation of the Smad pathway and inductive speci-
fication in dI neurons but is not involved in axonal
orientation. The similar dose-dependent stimulation of
Smad1/5/8 phosphorylation by BMP7 and BMP6 pro-
vides evidence that the Smad cascade is unlikely to med-
iate axonal orienting effects, which are selective to
BMP7. Indeed, at concentrations at which BMP7
actively evokes growth cone collapse, the Smad pathway
in dI neurons appears not to be engaged. In addition, in
dissociated dI neurons and explants, BMP-evoked phos-
phorylation of Smad1/5/8 was blocked by DM whereas
neither growth cone collapse nor axon orientation
responses to BMP7 were affected. In contrast, ectopic
dI1 neuronal differentiation marked by Lhx2/9 expres-
sion was blocked by inhibition of type I BMP receptor
kinase activity with the associated blockade of Smad1/5/
8 phosphorylation. Importantly, although Smad1/5/8
phosphorylation and dI neuronal specification respond
similarly to all treatments, we have not established
directly that Smad activity transduces BMP-evoked
neural specification. Other activators downstream of
type I BMP receptors may represent Smad1/5/8-inde-
pendent mediators of inductive pathways signaled by
BMPs [37,38]. Nonetheless, together, these findings indi-
cate divergence of the signaling underlying the inductive
and orienting responses of dI neurons to BMP7.
Type I BMP receptor kinase activity is not required
for the chemotropic activity of BMP7, posing the ques-
tion of how an axon orienting signal is generated. Three
lines of evidence suggest that stimulation of PI3K activ-
ity represents a pathway selected by BMP7 to evoke
axonal orientation and provide further support to the
model for independence of BMP7 signaling pathways.
First, at the low concentrations at which BMP7 stimu-
lates growth cone collapse in dI neurons, PI3K-depen-
dent signaling, but not Smad1/5/8 phosphorylation, is
activated by BMP7. Second, BMP6 does not stimulate
PI3K-dependent Akt activity in dI neurons at any con-
centration tested, paralleling its lack of orienting ability.
Figure 9 Model of divergent BMP signaling pathways
controlling transcriptional and cytoskeletal responses. The
distinct responses of dI neurons to BMP7 (neural induction and
axon orientation) occur through independent pathways. The neural
specification pathway, activated by both BMP7 and BMP6, at ‘high’
concentrations, leads to stimulation of the Smad cascade and
induction of target genes. This signaling pathway requires the
kinase activity of type I BMP receptors but appears not to depend
on specific type II BMP receptors. The chemotropic response of dI
neurons, axon orientation and growth cone collapse, is evoked by
BMP7 but not BMP6, is activated at low concentrations of agonist
and is not dependent on type I BMP receptor activity. Rather, this
path involves PI3K-dependent signaling mechanisms and may be
initiated through recruitment of a specific type II receptor pair
selectively by BMP7.
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growth cone collapse and orientation of spinal axons,
but not of BMP-evoked neuronal specification, suggests
the involvement of PI3K as a signaling component selec-
tive to the orienting activity of BMP7. Similar results
were obtained with two distinct inhibitors, supporting
the view that PI3K was the target and is a mediator in
this pathway. PI3K is known to be an intermediate in
pathways that regulate cell motility and migration
[39,40], raising the possibility that indiscriminate block-
ade of growth cone cytoskeletal dynamics underlies the
block of BMP7-evoked axon orientation. Against this
argument, Netrin-1-evoked axon orientation was unaf-
fected by blockade of PI3K activity, indicating selectivity
of the BMP7-evoked pathway for axon orientation.
Several intracellular mediators, PI3K, LIMK and Rho
GTPases, have been implicated in BMP-evoked chemo-
taxis [10,21], growth cone and axon orientation and the
dynamics of axon extension ([16,20] and current study).
How do these related signals conspire to elicit BMP-
dependent cytoskeletal reorganization? Our results add
to the increasing evidence for a BMP-evoked chemotro-
pic signaling pathway that includes PI3K, likely activated
by type II BMP receptors. Through the action of down-
stream pathway components, such as Rho GTPases,
PI3K activation may lead to oriented regulation of cytos-
keletal dynamics [40-43]. BMP-activated LIMK, in part-
nership with cofilin, may act in parallel to regulate the
rate of response to the chemorepellent BMP7 [16].
Nonetheless, details of the interactions and hierarchies
in this pathway remain to be determined.
The origins of BMP7 signaling divergence
The problem of how morphogens elicit both inductive
and tropic actions has recently been addressed for
Wnt and Hh proteins. In these cases, regulation of
intracellular responses appears to depend on differen-
tial expression and activation of canonical and distinct,
non-canonical, receptors and co-receptors [5,6,44,45],
although so far in separate cells. In a departure from
this theme, BMPs appear to activate variously grouped
subsets of a relatively small collection of canonical
BMP receptors to elicit differential responses
[10,18,28,46], which, importantly, can occur in an indi-
vidual cell ([9,10] and this study). This suggests that
the point of divergence of the cellular responses to the
same BMP lies with differential canonical receptor
engagement.
I nt h i ss t u d yw eh a v en o te s t a b l i s h e dh o wB M P 7
engages receptors selectively. Smad1/5/8 phosphoryla-
tion and dI neuron specification occur only in
response to relatively high doses of BMP7 or BMP6,
suggesting a lack of receptor selectivity, a notion sup-
ported by observations on receptor redundancy in
long-term BMP responses in monocytes and neurons
[10,25,28,47]. In contrast, the inability of BMP6 to
evoke chemotropic responses or activate downstream
signaling relevant to cytoskeletal dynamics, at any of a
wide range of concentrations tested, supports the idea
of an orientation-specific receptor complex. The com-
bination of type I and type II BMP receptor subunits
that mediates orientation is activated by low concen-
trations of BMP7. This complex can also be activated
at the substantially higher concentration at which
BMP7 activates the inductive pathway, suggesting that
BMP7 is able to recruit selectively the receptor com-
plex involved in orientation.
Which receptor subunits comprise the complex that
mediates orientation? We have demonstrated the
requirement for an unusual pairing of type II BMP
receptors, ActRIIA and BMPRII, in mediating the che-
moattractant effects of BMP7 in monocytic cell chemo-
taxis [10]. Moreover, the type I BMP receptor BMPRIB
has been implicated in dI axon guidance, with selectivity
over BMPRIA [28]. Our finding that the kinase activity
of type I BMP receptors is not necessary for BMP7-
evoked growth cone collapsing activity or axonal orien-
tation leads us to propose that the requirement for
BMPRIB in axonal responses reflects a role for this sub-
unit independent of its kinase activity, perhaps acting to
maintain a particular structural conformation of the
ActRIIA/BMPRII/BMPRIB receptor complex. Whether
BMPRIB is required physically to support the functional
activation of a discrete set of type II BMP receptor sub-
units that direct the PI3K-dependent cascade to axon
orientation needs further studies.
How might a distinct assembly of type II BMP recep-
tor subunits direct the orienting responses of chemo-
tropic BMPs? The choice of downstream pathway may
depend on the mode of receptor oligomerization upon
binding to BMP7: whether BMPs bind to preformed
receptor complexes present in the membrane or initi-
ate ligand-induced receptor complex assembly has
been shown to dictate cellular response [48,49]. Dis-
tinct signaling information generated by identical
receptors arranged variably within the receptor com-
plex [50,51] seems unlikely in the case of dI neurons
since BMP7 continues to orient axons at the higher
concentration required for the inductive response. In
dI neurons, the thresholds for BMP7 activation of
Smad1/5/8 and PI3K (and accompanying inductive
specification and orienting responses) suggest that dif-
ferent affinities of BMPs for distinct receptor subunits
influence signaling outcomes. Further studies will be
required to understand how BMP7 achieves selective
recruitment of BMP receptors and the details of how
this translates into differential activity of two signaling
pathways.
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In dorsal spinal neurons inductive and axon orienting
responses represent sequential steps in the differentiation
of single neurons. We show here, however, that the two
classes of response can also be evoked concurrently in
individual dI neurons. Our results suggest that inductive
specification and axonal orientation arise from activation
of different receptor complexes. The activation of Smads
and associated specification of dI1 neurons by BMP7 or
BMP6 depend on type I BMP receptor activity. Conver-
sely, the ability of BMP7 to orient axons and growth
cones does not depend on a pathway initiated by type I
BMP receptor activity, relying instead on a distinct cas-
cade of cytoskeletal activators, including PI3K, that likely
result from engagement of type II BMP receptors.
Materials and methods
Antibodies and reagents
Recombinant BMPs were purchased from R&D Systems,
Minneapolis, MN, USA, and stock solutions were pre-
pared in 4 mM HCl/0.1% BSA. Pharmacological reagents:
LY (Cell Signaling Technology, Danvers, MA, USA) and
WM (Sigma (St Louis, MO, USA)) for PI3K; DM (Sigma)
for type I BMP receptor activity; PD98059 for Erk1/2
MAPK (Calbiochem, San Diego, CA, USA), SB203580 for
p38 MAPK (Calbiochem), KT5720 for protein kinase A
inhibition (Calbiochem) and forskolin for adenylate cyclase
activation (Calbiochem). Each stock solution for the phar-
macological reagents was prepared in DMSO and subse-
quently diluted in medium as specified. Antibodies were:
mouse a- T A G - 1( 4 D 7[ 5 2 ] ) ;r a b b i ta-Lhx2/9 (L1 [11]);
mouse a-ERM (13H9 [53]); rabbit a-Smad1/5/8 (N18;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit
a-phospho-Smad1/5/8 (pSmad); rabbit a-phospho-Akt(S)
(pAkt) and rabbit a-Akt (Cell Signaling Technology);
mouse a-flag (M2; Sigma); rat a-Netrin-1 (R&D Systems);
rabbit a-ActRII (H65) and goat a-ActRIIB (N16) (Santa
Cruz); mouse a-ActRIIB (abcam, Cambridge, MA USA);
and mouse a-BMPRII (BD Transduction Laboratories,
San Jose, CA, USA). We were unable to detect expression
of ActRIIA using available ActRIIA-specific antibodies.
However, an antibody that recognizes both ActRIIA and
ActRIIB, a-ActRII (H65), preferentially detected the 70
kDa ActRIIA protein expressed in dI neurons (Figure 4A,
lane 2). HRP- and fluorophore-conjugated secondary anti-
bodies were purchased from Jackson ImmunoResearch
Laboratories, West Grove, PA, USA. Cell culture reagents
were: Ham’s F12 medium, OptiMEM medium, penicillin/
streptomycin/glutamine (P/S/G), penicillin/streptomycin
(P/S), N2 supplement (Invitrogen, Carlsbad, CA, USA),
FBS (Gemini BioProducts, West Sacramento, CA, USA),
fibronectin (Sigma) and 45% glucose (Sigma). The mature
region of mouse flag-tagged BMP7 was cloned into
pMT23 as previously described [11,12]. Mouse Netrin-1.
pMT23 was generously provided by Dr Thomas Jessell
(Columbia University).
Dissociated dI neuron culture
Embryonic day (E)13 rat dorsal spinal cord was dissected
as previously described [3] in L15 medium (Sigma) and
dissociated in 0.35% trypsin/0.2% glucose/PBS/P/S at 37°
C for 15 minutes. Following trypsin digestion, the tissue
was resuspended in culture medium (F12/10% FBS/P/S/
G) and gently triturated. The single cell suspension was
plated in culture medium onto poly-D-lysine/laminin-
coated tissue culture dishes (western blot analysis) or 12
mm glass coverslips (immunolabeling) and incubated
overnight at 37°C, 5% CO2. When required, dissociated
dI neuron cultures were serum starved by incubation in
non-supplemented F12 medium for 2 h at 37°C.
Immunolabeling of dI neurons
Dissociated dI neuron cultures were fixed in 4% parafor-
maldehyde/PBS for 10 minutes, washed once in PBS,
b l o c k e da n dl a b e l e dw i t hp r i m a r ya n dC y 3 - c o n j u g a t e d
secondary antibodies diluted in 1% heat-inactivated goat
serum or FBS/0.1% Triton X-100/PBS. For nuclear co
labeling, DAPI (2.5 μg/ml; Sigma) was added with the
secondary antibody. Coverslips were mounted onto glass
microscope slides in Vectashield (Vector Laboratories,
Inc., Burlingame, CA, USA).
Phosphorylation assays
For phosphorylation assays, serum-starved dissociated dI
neuron cultures were treated with either 4 mM HCl/
0.1% BSA (control), BMP7 or BMP6, diluted in non-
supplemented F12 medium at the indicated concentra-
tions before immunolabeling with a-pSmad1/5/8 or a-
pAkt or preparation of cell lysates for western blot ana-
lysis. BMP-treated [i] explants were labeled with a-phos-
pho-Smad1/5/8.
Western blot analysis
Whole cell lysates of dI neuron cultures were prepared
using 1x lysis buffer (Cell Signaling Technology) supple-
mented with 1 mM PMSF. Samples were separated by
SDS-PAGE (EZ-Run Gel Solution, Fisher Scientific,
Pittsburgh, PA, USA) and transferred to nitrocellulose
(Whatman, Clifton, NJ, USA). Nitrocellulose membranes
were blocked in 5% nonfat milk/0.1% Tween 20/TBS
(blocking buffer) and probed overnight with primary
antibodies diluted in 5% BSA/0.1% Tween 20/TBS,
except for the a-BMPRII and a-ActRIIB monoclonal
antibodies, which were diluted in blocking buffer. Mem-
branes were washed in TBST (0.1% Tween 20/TBS) and
probed (1 hour) with HRP-conjugated secondary antibo-
dies in blocking buffer. After washing in TBST, blots
were developed using the Supersignal West Pico
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moScientific, Rockland, IL, USA) and exposed to Kodak
BioMax Light Film. For phosphorylation assays, mem-
branes were washed in TBS, stripped for 30 minutes at
70°C in stripping buffer (62.5 mM Tris pH 6.8/2% SDS/
0.1 M a-mercaptoethanol), washed in TBS and reprobed
using antibodies that recognize total cellular Smad1/5/8
or Akt for normalization of the phosphorylated signals.
The films were imaged using the Kodak Digital Science
Image Station 440CF and densitometric analysis was
performed using ImageJ v1.37 software (NIH).
Growth cone collapse assay
Serum-starved dissociated dI neuron cultures were pre-
incubated with DMSO (control), PI3K inhibitors (1
hour) or DM (30 minutes), diluted in non-supplemented
F12 medium, and then stimulated with 50 ng/ml BMP7
or treated with 4 mM HCl/0.1% BSA (control) for 30
minutes. The cultures were fixed in pre-warmed 4% par-
aformaldehyde/0.5% gluteraldehyde/0.1 M phosphate
buffer for 5 minutes, washed once in PBS, blocked in
1% heat-inactivated goat serum/0.1% Triton X-100/PBS
and labeled with a mouse a-ERM IgM and a Cy3 goat
a-mouse IgM secondary antibody. The growth cone
area of neurons with axons greater than 10 μmw a s
measured across two or three coverslips per condition
for each experiment using ImageJ v1.37 software (NIH).
Growth cone collapsing activity is presented as raw
mean area or as the percentage decrease of growth cone
area relative to control cultures.
[i] explant assays
[i] explants were dissected from stage 10 chick embryos
a n dc u l t u r e di nc o l l a g e na n di m m u n o l a b e l e da sp r e -
viously described [54,55]. BMPs or 4 mM HCl/0.1%
BSA (control), with and without DMSO (control), DM
or LY, were diluted in F12/N2 supplement/fibronectin/
P/S) and incubated with the explants for 48 hours.
[d] explant assays
E11 rat [d] explants were dissected, cultured and labeled
as previously described [3]. For BMP7, BMP7:GDF7 or
Netrin-1 expression, COS-1 cells were transfected with
pMT23 expression constructs using Lipofectamine
Reagent (Invitrogen), aggregated [56] and appended to
[d] explants as described [3]. Inhibitors or DMSO (con-
trol), diluted in OptiMEM/P/S/G culture medium, were
added at the beginning of the 36-h culture period.
Explants were immunolabeled as described above.
Quantification of Lhx2/9 induction, using ImageJ v1.37
software (NIH), was performed by measuring the inte-
grated density (mean pixel intensity × area) of the
BMP7-induced region of Lhx2/9
+ cells present in the
explant. The angle of reorientation was measured as
shown previously [3]. We observed similar induction of
Lhx2/9 and axon orientation activity using COS-1 cell
aggregates expressing either the BMP7 homodimer or
the BMP7:GDF7 heterodimer [4] in [d] explant axon
orientation assays with and without LY and present the
combined data in Figures 5D and 6B.
DM treatment
Dissociated dI neurons were pretreated with DM vehicle
in solution or with 10 μM DM for 30 minutes and then
incubated with BSA vehicle (control), or indicated
BMPs, at 50 ng/ml for 30 minutes. In explants assays,
DM was added at the time of culture, as were all other
reagents. Dose response analysis was performed to
d e t e r m i n ea ne f f e c t i v ed o s ef o rb l o c k a d eo ft y p eIB M P
receptor kinase activity. Dissociated dI neurons, and [i]
and [d] explants were treated with a range of DM con-
centrations (0 to 20 μM) for 30 minutes and then incu-
bated with BSA vehicle (control) or BMPs. At 20 μM,
neurons became unhealthy and were not further
included in the study. At 0.1 and 1 μM there were no
observable effects of DM treatment (not shown). DM
was effective at 5 and 10 μM and these doses were used
for all further experiments.
LY and WM treatment
Dissociated dI neurons were pretreated with inhibitor
vehicle solution, 50 μM LY or 100 nM WM for 1 h and
stimulated with 50 ng/ml BMP7 or control for 30 min-
utes. For explants, 2.5 μML Yo r5 0n MW Mw e r e
added to explants at the time of culture.
Imaging
Images of dI neuron dissociated cultures and explants
were taken with a Zeiss AxioCam HR digital camera
mounted on a Zeiss Axiovert 200 M fluorescence micro-
scope. In addition, images of [i] and [d] explants were
taken using a Zeiss LSM 5 confocal microscope and are
presented here as confocal Z-stacks.
Additional material
Additional file 1: Figure S1 - BMP7-mediated axon orientation is
insensitive to changes in cAMP- and MAPK-dependent activity.
Histograms of the angle of reorientation in [d] explants co-cultured as in
Figures 3D and 6A with pMT23- (dark gray bars) or BMP7-expressing
(light gray bars) COS-1 cell aggregates incubated with or without
inhibitors or activators as indicated. None of the reagents tested had any
significant effect (Student’s t-test) on control (pMT23) [d] explant co-
cultures or on the repellent activity of BMP7 in [d] explant co-cultures.
Results are expressed as the mean ± SEM for each condition. Angles of
reorientation: control (pMT23) = -0.45 ± 1.8° (n = 11); BMP7 = 32.8 ± 1.6°
(n = 35). PKA inhibitor (1 μM KT5720): pMT23 = -5.0 ± 2.1° (n = 3); BMP7
= 32.0 ± 2.9° (n = 7). Adenylate cyclase activator (4 μM forskolin): pMT23
= -1° (n = 1); BMP7 = 21.8 ± 4.9° (n = 4). Erk1/2 MAPK inhibitor (50 μM
PD98059): pMT23 = -1.6 ± 2.3° (n = 3)); BMP7 = 28.0 ± 5.3° (n = 5). p38
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31.0 ± 2.3° (n = 3).
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ActR: activin-like receptor; BMP: bone morphogenetic protein; BMPR: bone
morphogenetic protein receptor; BSA: bovine serum albumin; [d] explants:
explant of E11 rat dorsal spinal cord; DM: dorsomorphin; DMSO: dimethyl
sulfoxide; dI dorsal spinal interneuron; E: embryonic day where E0.5 = 6 am
on the day of plug; ERM: ezrin-radixin-moeisin; FBS: fetal bovine serum; HRP:
horseradish peroxidase; [i] explant: explant of intermediate region of spinal
cord of Hamburger Hamilton Stage 10 chick embryo; LIMK: LIM domain
kinase; LY: LY294002; MAPK: mitogen-activated protein kinase; PBS:
phosphate-buffered saline; PI3K: phosphoinositide-3-kinase; PKA: protein
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